FR-like EBNA1 binding repeats in the human genome

Virology

Volumn 405, Issue 2, 2010, Pages 524-529

  d'Hérouël, Aymeric Fouquier ^a   Birgersdotter, Anna ^b   Werner, Maria ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

EBNA1; Epstein Barr virus; Family of Repeats; Human binding sites

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; GENE PRODUCT; INTERFERON REGULATORY FACTOR 2 BINDING PROTEIN 2; INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1; IQ MOTIF CALCIUM ION BINDING PROTEIN 1; THYROID PEROXIDASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; COMPUTER PROGRAM; EPSTEIN BARR VIRUS; GENE IDENTIFICATION; GENETIC SCREENING; HUMAN GENOME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION;

AUTOANTIGENS; BINDING SITES; CALMODULIN-BINDING PROTEINS; CARRIER PROTEINS; DNA; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; GENOME, HUMAN; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; NUCLEAR PROTEINS; PROTEOGLYCANS; REPETITIVE SEQUENCES, NUCLEIC ACID;

HUMAN HERPESVIRUS 4;

EID: 77955661979     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.040     Document Type: Article

References (50)

1. Acharaya S., Rayborn M.E., Hollyfield J. Characterization of SPACR, a sialoprotein associated with cones and rods present in the interphotoreceptor matrix of the human retina: immunological and lectin binding analysis. Glycobiology 1998, 8:997-1006.
2. Almqvist J., Zou J., Linderson Y., Borestrom C., Altiok E., Zetterberg H., Rymo L., Pettersson S., Ernberg I. Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP. J. Gen. Virol. 2005, 86:1261-1267.
3. Ambinder R.F., Mullen M.A., Chang Y.N., Hayward G.S., Hayward S.D. Functional domains of Epstein-Barr virus nuclear antigen ebna-1. J. Virol. 1991, 65(3):1466-1478.
4. Ambinder R.F., Shah W.A., Rawlins D.R., Hayward G.S., Hayward S.D. Definition of the sequence requirements for binding of the ebna-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 1990, 64(5):2369-2379.
5. Avolio-Hunter T.M., Lewis P.N., Frappier L. Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication. Nucleic Acids Res. 2001, 29(17):3520-3528.
6. Babcock G.J., Hochberg D., Thorley-Lawson D.A. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000, 13:497-506.
7. Baumforth K.R.N., Birgersdotter A., Reynolds G.M., Wei W., Kapatai G., Flavell J.R., Kalk E., Piper K., Lee S., Machado L., Hadley K., Sundblad A., Sjoberg J., Bjorkholm M., Porwit A.A., Yap L.-F., Teo S., Grundy R.G., Young L.S., Ernberg I., Woodman C.B.J., Murray P.G. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of ccl20 and the migration of regulatory T cells. Am. J. Pathol. 2008, 173(1):195-204.
8. Blackwood E.M., Kadonaga J.T. Going the distance: a current view of enhancer action. Science 1998, 281:60-63.
9. Bochkarev A., Barwell J.A., Pfuetzner R.A., Bochkareva E., Frappier L., Edwards A.M. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, ebna1, bound to DNA. Cell 1996, 84(5):791-800.
10. Borza C.M., Hutt-Fletcher L.M. Alternative replication in b cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 2002, 8:594-599.
11. Canaan A., Haviv I., Urban A.E., Schulz V.P., Hartman S., Zhang Z., Palejev D., Deisseroth A.B., Lacy J., Snyder M., Gerstein M., Weissman S.M. Ebna1 regulates cellular gene expression by binding cellular promoters. Proc. Natl. Acad. Sci. 2009, 106(52):22421-22426.
12. Chardes T., Chapal N., Bresson D., Bes C., Giuducelli V., Lefranc M., peraldi Roux S. The human anti-thyroid peroxidase autoantibody repertoire in Grave's and Hashimoto's autoimmune thyroid diseases. Immunogenetics 2002, 54:141-157.
13. Childs K.S., Goodbourn S. Identification of novel co-repressor molecules for interferon regulatory factor-2. Nucleic Acids Res. 2003, 31(12).
14. Crooks G.E., Hon G., Chandonia J.M., Brenner S. Weblogo: a sequence logo generator. Genome Res. 2004, 14:1188-1190.
15. Desailloud R., Hober D. Viruses and thyroiditid: an update. Virol. J. 2009, 6(5).
16. Dresang L.R., Vereide D.T., Sugden B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (ebna1) in the human genome: defining a position-weighted matrix to predict sites bound by ebna1 in viral genomes. J. Virol. 2009, 83(7):2930-2940.
17. Flavell J.R., Baumforth K.R.N., Wood V.H.J., Davies G.L., Wei W., Reynolds G.M., Morgan S., Boyce A., Kelly G.L., Young L.S., Murray P.G. Down-regulation of the tgf/beta target gene, ptprk, by the Epstein/Barr virus encoded ebna1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 2008, 111:292-301.
18. Frappier L., O'Donnell M. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc. Natl Acad. Sci. USA 1991, 88(23):10875-10879.
19. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl Acad. Sci. USA 2009, 106(7):2313-2318.
20. Harada H., Fujita T., Miyamoto M., Kimure Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF/1 and IRF/2, bind to the same regulatory elements of IFN and IFN/inducible genes. Cell 1989, 58:729-739.
21. Holowaty M.N., Zeghouf M., Wu H., Tellam J., Athanasopoulos V., Greenblatt J., Frappier L. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 2003, 278:29987-29994.
22. Kennedy G., Komano J., Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl Acad. Sci. USA 2003, 100(24):14269-14274.
23. Kube D., Vockerodt M., Weber O., Hell K., Wolf J., Haier B., Grsser F.A., Mller-Lantzsch N., Kieff E., Diehl V., Tesch H. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of cd25 in the Hodgkin cell line l428. J. Virol. 1999, 73(2):1630-1636.
24. Lindberg U., Schutt C.E., Goldman R.D., Nyakern-Meazza M., Hillberg L., Ratjhe L., Grenklo S. Tropomyosins regulate the impact of actin binding proteins on actin filaments. Adv. Exp. Med. Biol. 2008, 644:223-231.
25. Luo X., He Q., Huang Y., Sheikh M.S. Cloning and characterization of a p53 and DNA damage down-regulated gene PIQ that codes for a novel calmodulin-binding IQ motif protein and is up-regulated in gastrointestinal cancers. Cancer Res. 2005, 65:10725-10733.
26. Luo X., He Q., Huang Y., Sheikh M.S. Transcriptional upregulation of puma modulates endoplasmic reticulum calcium pool depletion/induced apoptosis via bax activation. Cell Death Differ. 2005, 12:1310-1318.
27. Murakami M., Lan K., Subramanian C., Robertson E.S. Epstein-Barr virus nuclear antigen 1 interacts with nm23-h1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J. Virol. 2005, 79:1559-1568.
28. Narlikar L., Ovcharenko I. Identifying regulatory elements in eukaryotic genomes. Brief. Funct. Genomic Proteomic 2009, 8(4):215-230.
29. Nonkwelo C., Ruf I.K., Sample J. Interferon-independent and -induced regulation of Epstein-Barr virus ebna/1 gene transcription in Burkitt lymphoma. J. Virol. 1997, 71(9):6887-6897.
30. O'Flanagan R.A., Paillard G., Lavery R., Sengupta A.M. Non-additivity in protein-DNA binding. Bioinformatics 2005, 21(10):2254-2263.
31. O'Neil J.D., Owen T.J., Wood V.H.J., Date K.L., Valentine R., Chukwuma M.B., Arrand J.R., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol. 2008, 89(Pt 11):2833-2842.
32. Petgel D.M., Middeldorp J., Thorley-Lawson D.A. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J. Virol. 2004, 78(22):12613-12624.
33. Resiman D., Sugden B. trans activation of am Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 1986, 6(11):3838-3846.
34. Sample J., Henson E.D., Sample C. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol. 1992, 66(8):4654-4661.
35. Schaefer B.C., Paulson E., Strominger J.L., Speck S.H. Constitutive activation of Epstein/Barr virus *ebv( nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted ebv latency. Mol. Cell. Biol. 1997, 17(2):873-886.
36. Schulz T.F., Cordes S. Is the Epstein-Barr virus ebna-1 protein an oncogen?. Proc. Natl Acad. Sci. USA 2009, 106(7):2091-2092.
37. Sengupta S., den Boon J.A., Chen I.-H., Newton M.A., Dahl D.B., Chen M., Cheng Y.-J., Westra W.H., Chen C.-J., Hildesheim A., Sugden B., Ahlquist P. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 2006, 66(16):7999-8006.
38. Shimon I., Pariente C., Shlomo-David J., Grossman Z., Sack J. Transient elevation of triiodothyronine caused by triiodothyronine autoantibody associated with acute Epstein-Barr-virus infection. Thyroid 2003, 13(2):211-215.
39. Srinivas S.K., Sixbey J.W. Epstein-Barr virus induction of recombinase-activating genes rag1 and rag2. J. Virol. 1995, 69(12):8155-8158.
40. Su W., Middleton T., Sugden B., Echols H. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl Acad. Sci. USA 1991, 88(23):10870-10874.
41. Summers H., Barwell J.A., Pfuetzner R.A., Edwards A.M., Frappier L. Cooperative assembly of ebna1 on the Epstein-Barr virus latent origin of replication. J. Virol. 1996, 70(2):1228-1231.
42. Vrbikova J., Janatkova I., Zamrazil V., Tomiska F., Fucikova T. Epstein-Barr virus serology in patients with autoimmune thyroiditis. Exp. Clin. Endocrinol. Diab. 1996, 104(1):89-92.
43. Wang J., Lindner S.E., Leight E.R., Sugden B. Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol. Cell. Biol. 2006, 26(3):1124-1134.
44. Werner M., Ernberg I., Zou J., Almqvist J., Aurell E. Epstein-Barr virus latency switch in human B-cells: a physico-chemical model. BMC Syst. Biol. 2007, 1:40.
45. Werner M., Zhu L., Aurell E. Cooperative action in eukaryotic gene regulation: physical properties of a viral example. Phys. Rev. E Stat. Nonlin. Soft Matter. Phys. 2007, 76:061909.
46. Wilson J.B., Bell J.L., Levine A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996, 15(12):3117-3126.
47. Wilson J.B., Levine A.J. The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr. Top. Microbiol. Immunol. 1992, 182:375-384.
48. Wysokenski D.A., Yates J.L. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J. Virol. 1989, 63(6):2657-2666.
49. Zetterberg H., Borestrm C., Nilsson T., Rymo L. Multiple ebna1-binding sites within oripi are required for ebna1-dependent transactivation of the Epstein-Barr virus C promoter. Int. J. Oncol. 2004, 25(3):693-696.
50. Zhang Y., Chang C., Gehling D.J., Hemmati-Brivanou A., Derynck R. Regulation of smad degradation and activity by smurf, an e3 ubiquitin ligase. Proc. Natl Acad. Sci. USA 2001, 98:974-979.